Steven Kelly serves as Executive at CytRx Oncology Corp, where they oversee executive responsibilities. Since joining the company, Steven Kelly has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 19, 2008 involved selling 158,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 19, 2008 | IVPH.OB | $0 | Disposition | 158,000 | $N/A | Discretionary |
Steven Kelly currently holds 0 shares of CytRx Oncology Corp (IVPH.OB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven Kelly has been a net neutral trader of IVPH.OB stock. They have purchased $0 and sold $0 worth of shares.
Steven Kelly's most recent insider trade was on Sep 19, 2008, when they sold 158,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted